CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 108 filers reported holding CHEMOCENTRYX INC in Q4 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,520,000 | +2300.0% | 106,862 | +332.6% | 0.01% | +700.0% |
| Q2 2019 | $230,000 | -94.9% | 24,700 | -92.4% | 0.00% | -90.9% |
| Q1 2019 | $4,511,000 | +88.0% | 324,748 | +47.6% | 0.01% | +83.3% |
| Q4 2018 | $2,400,000 | -9.9% | 220,004 | +4.4% | 0.01% | 0.0% |
| Q3 2018 | $2,664,000 | +111.8% | 210,762 | +120.7% | 0.01% | +100.0% |
| Q2 2018 | $1,258,000 | +170.5% | 95,494 | +179.1% | 0.00% | +200.0% |
| Q1 2018 | $465,000 | +200.0% | 34,216 | +31.5% | 0.00% | – |
| Q4 2017 | $155,000 | +15.7% | 26,016 | +44.5% | 0.00% | – |
| Q3 2017 | $134,000 | – | 17,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |